 Call scheduled for Monday, December 5, 2022 at 8:00 a.m. ET SOUTH SAN FRANCISCO, Calif., Dec. 02, 2022 GLOBE NEWSWIRE Nkarta, Inc. Nasdaq: NKTX, a biopharmaceutical company developing engineered natural killer NK cell therapies to treat cancer, today announced that it will host a conference call on Monday, December 5, 2022 at 8:00 a.m. ... The post Nkarta to Host Conference Call to Discuss Updated Clinical Data from NKX019 NK Cell Therapy Program appeared first on ForexTV... 